Effects of low dose warfarin and losartan especially in old patients with nonvaluvular atrial fibrillation

Effects of low dose warfarin and losartan especially in old patients with nonvaluvular atrial fibrillation - HAKODATE atrial fibrillation study

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-C000000016

Enrollment

300

Registered

2007-08-01

Start date

2005-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nonvaluvular atrial fibrillation

Interventions

minimum-dose warfarin(INR1.5-1.9) minimum-dose warfarin(INR1.5-1.9) with losartan 50mg low-dose warfarin(INR2.0-2.4) low-dose warfarin(INR2.0-2.4) with losartan 50mg

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: all(no age limitation) nonvalvular atrial fibrillation

Exclusion criteria

Exclusion criteria: risk of major bleeding cancer dementia severe liver dysfunction severe renal dysfunction

Design outcomes

Primary

Measure	Time frame
embolism major bleeding	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026